MYMD
MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immunometabolic system to control TNF-α and other pro-inflammatory cytokines. MYMD-1 is being developed to treat autoimmune diseases, including those currently treated with non-selective TNF-α blocking drugs, and aging and longevity. SUPERA-CBD is a drug platform based o... n a novel (patent pending) synthetic derivative of cannabidiol (CBD) that targets numerous key receptors including CB2 and opioid receptors and inhibits monoamine oxidase. SUPERA-CBD is being developed to address the rapidly growing CBD market, that includes FDA approved drugs and CBD products not currently regulated as a drug.
MYMD
Social Links:
Industry:
Biotechnology Pharmaceutical
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.mymd.com
Status:
Active
Contact:
(813) 864-2566
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag
Similar Organizations
Algabt
AlgaBT is an algae company for carotenoid production.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
P2D Bioscience
This company is a specialty pharmaceutical company focused on developing innovative drugs.
Rhizen Pharmaceuticals
Rhizen is a clinical-stage biopharmaceutical company focused on discovery and development of innovative.
Seyer Pharmatec
This company is a medium sized pharmaceutical companies face a wide array of challenges in developing their products.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-04-16 | Akers Biosciences | Akers Biosciences acquired by MyMD | N/A |
Official Site Inspections
http://www.mymd.com Semrush global rank: 3.9 M Semrush visits lastest month: 3.26 K
- Host name: 151.101.194.159
- IP address: 151.101.194.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "MyMD"
MyMD - Crunchbase Company Profile & Funding
MYMD-1 is being developed to treat autoimmune diseases, including those currently treated with non-selective TNF-α blocking drugs, and aging and longevity. SUPERA-CBD is a drug …See details»
MyMD Pharmaceuticals Announces Corporate Rebranding to New …
BALTIMORE, July 22, 2024--TNF Pharmaceuticals, Inc., formerly MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD) (the "Company"), a clinical stage biopharmaceutical company committed to …See details»
SEC.gov | HOME
Management and Organization . The combined company will be led by Chris Chapman, M.D., who will become President and Chief Medical Officer of MyMD, and Adam Kaplin, M.D., who …See details»
MyMD Pharmaceuticals ® Letter to Shareholders
Dec 14, 2021 MyMD supported the Arthritis Foundation’s Commitment to a Cure Gala on October 28th where I was recognized as the Medical Honoree. I am deeply honored by this …See details»
MyMD Pharmaceuticals Secures Strategic Investments - Yahoo …
BALTIMORE, May 21, 2024--MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) ("MyMD" or "the Company"), a clinical stage biopharmaceutical company committed to developing novel …See details»
MyMD Pharmaceuticals - VentureRadar
MyMD is a clinical-stage pharmaceutical company focused on the development of drug products that represent a transformation in the targeting of aging and age-related diseases; …See details»
MyMD Pharmaceuticals Announces New Data on Its Lead …
Feb 23, 2021 BALTIMORE--(BUSINESS WIRE)--Feb 23, 2021-- Akers Biosciences, Inc. (Nasdaq: AKER), with its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a …See details»
MyMD - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 21, 2024: Post-IPO Equity …See details»
MyMD Pharmaceuticals, Inc. (MYMD): history, ownership, mission, …
Recent Developments. In August 2023, MyMD Pharmaceuticals announced significant progress in its clinical trials, securing additional funding of $15 million to support ongoing research and …See details»
MyMD - Contacts, Employees, Board Members, Advisors & Alumni …
MyMD is a clinical-stage pharmaceutical company focused on the development of drug products.See details»
MyMD Pharmaceuticals® Accelerates Pace of New Patient Dosing …
A discussion of these and other factors with respect to MyMD is set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed by MyMD on March 31, …See details»
MyMD Pharmaceuticals® Provides Dosing Update on Phase 2 …
Apr 12, 2023 BALTIMORE, MD--(BUSINESS WIRE)-- MyMD Pharmaceuticals, Inc. ® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company developing …See details»
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin …
Nov 16, 2021 A discussion of these and other factors with respect to MyMD is set forth in the Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, filed by MyMD …See details»
MYMD
Jump into the details directly on the myMD platform or talk to a health professional. Discover our platform. Clinically curated wellness journeys. myMD has been built for patients using the …See details»
FDA Accepts MyMD Pharmaceuticals’ Investigational New Drug …
Aug 14, 2023 A discussion of these and other factors with respect to MyMD is set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed by …See details»
MYMD
Presenting myMD, an innovative employee wellbeing platform that cultivates shared values and enhances the health and wellbeing of employees. Through incentivized health activities, …See details»
MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of …
Dec 6, 2023 MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age …See details»
Home | MyMD
MyMD is your go-to health platform. Access support and coaching on Healthy Living, Eating Well, Stress, Parenting, and more! Start exploring now!See details»
MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shown to …
MyMD is collaborating with a major medical school for a Phase 2 clinical trial to investigate the effectiveness of MYMD-1 to treat immune mediated depression and cytokine elevation in …See details»
Doctor Reviews & Ratings - Find a Doctor at RateMDs
Search or browse RateMDs for trusted reviews & ratings on doctors & healthcare facilities. We're the original doctor ratings site with over 2 million reviews.See details»